Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4

Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4

Jiang-Tao Zhang,1 Jun Chen,2 Hui-Chao Ruan,1 Feng-Xi Li,3 Sen Pang,1 Yu-Ju Xu,1 Dao-Lai Huang,1 Xiang-Hua Wu1 1Department of Gastrointestinal and Gland Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People’s Republic of China; 2Department...

Full description

Bibliographic Details
Main Authors:	Zhang JT, Chen J, Ruan HC, Li FX, Pang S, Xu YJ, Huang DL, Wu XH
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-11-01
Series:	Cancer Management and Research
Subjects:	breast cancer adriamycin resistance mir-15a-5p cdca4 cell-free nucleic acids molecular targets breast cancer patient stratification
Online Access:	https://www.dovepress.com/microribonucleic-acid-15a-5p-alters-adriamycin-resistance-in-breast-ca-peer-reviewed-fulltext-article-CMAR

Similar Items

The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
by: Ying Zhu, et al.
Published: (2013-11-01)

NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
by: Huanhuan Sha, et al.
Published: (2023-03-01)

Longitudinal melanonychia and distal onycholysis associated with 5-fluorouracil/adriamycin/cyclophosphamide chemotherapy for breast cancer
by: Marta Żywno, et al.
Published: (2021-12-01)

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
by: Yousif A. Kariri, et al.
Published: (2022-11-01)

Effects of Adriamycin-Cytoxan chemotherapy on hematological and electrolyte parameters among breast cancer patients
by: Fikremariam Abiye Tadesse, et al.
Published: (2023-05-01)

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer
by: Boxue Ren, et al.
Published: (2019-03-01)

HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance
by: Yunxia Xie, et al.
Published: (2022-07-01)

Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
by: Chunli Tan, et al.
Published: (2021-05-01)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
by: Qi Min, et al.
Published: (2021-01-01)

Afatinib Sensibilizes Multidrug-resistant Human Ovarian Cancer Cells to Adriamycin and Related Mechanisms
by: ZHANG Yunqi, et al.
Published: (2018-10-01)

Dimethyl Fumarate Induces Apoptosis via Inhibition of NF-κB and Enhances the Effect of Paclitaxel and Adriamycin in Human TNBC Cells
by: Katsumasa Tsurushima, et al.
Published: (2022-08-01)

SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
by: Xu Chen, et al.
Published: (2018-05-01)

MicroRNA‐221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling
by: Yingchun Yin, et al.
Published: (2020-02-01)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
by: Le Van Manh Hung, et al.
Published: (2018-03-01)

Adriamycin Induced Chemoresistance of Human TNBC MDA-MB-468 Cells Through Stat3-cMyc Signal Pathway
by: XU Jinyuan, et al.
Published: (2018-12-01)

MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4
by: Guang-Chao Wang, et al.
Published: (2016-06-01)

Assessment of the Nutraceutical Effects of Oleuropein and the Cytotoxic Effects of Adriamycin, When Administered Alone and in Combination, in MG-63 Human Osteosarcoma Cells
by: Katerina Gioti, et al.
Published: (2021-01-01)

Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
by: Yangling Li, et al.
Published: (2017-06-01)

Modifications of The Human Liver Cancer Cells through microRNA-145-Mediated Targeting of CDCA3
by: Yongqiang Lai, et al.
Published: (2023-08-01)

Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor‐targeted chemotherapy of lung cancer
by: Xiang Liang, et al.
Published: (2021-05-01)

Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells
by: Yaru Li, et al.
Published: (2021-11-01)

Alterations in serum levels of trace element in patients with breast cancer before and after chemotherapy
by: norjis ahmadi, et al.
Published: (2018-01-01)

A Case of a Rapidly Growing Granulocyte Colony-Stimulating Factor-Producing Squamous Cell Carcinoma of the Breast
by: Haruna Noda, et al.
Published: (2021-08-01)

Adriamycin-induced fetal hydronephrosis
by: Anderson Gonçalves, et al.
Published: (2004-12-01)

Lisinopril Protects Against the Adriamycin Nephropathy and Reverses the Renalase Reduction: Potential Role of Renalase in Adriamycin Nephropathy
by: Pengxun Han, et al.
Published: (2013-09-01)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
by: Weiming Zhu, et al.
Published: (2013-11-01)

Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
by: Xiaoping Pan, et al.
Published: (2020-04-01)

EFFECT OF SEVOFLURANE EXPOSURE ON ADRIAMYCIN-INDUCED INJURIES TO MYOCYTES
by: Li-hua Fan, et al.
Published: (2014-01-01)

CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
by: Dongwei Dou, et al.
Published: (2020-09-01)

Implications of cell division cycle associated 4 on the Wilm’s tumor cells viability via AKT/mTOR signaling pathway
by: Suqing Li, et al.
Published: (2021-01-01)

Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity
by: Akin Ali Tuğrul, et al.
Published: (2021-01-01)

Adriamycin activity's durational governance of different cell death types and zonality in rat liver acinus. Immunohistochemical studies
by: Pedrycz Agnieszka, et al.
Published: (2014-03-01)

Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice
by: Ryoichi Matsuda, et al.
Published: (2013-07-01)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
by: Yingying Wang, et al.
Published: (2020-02-01)

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome
by: Juan Lv, et al.
Published: (2023-01-01)

Construction of a mouse model of adriamycin-induced cardiomyopathy
by: ZHANG Qingling, ZHANG Yunpeng, ZHOU Zandong, ZHANG Yue, LIU Tong
Published: (2022-10-01)

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
by: Barrett D. Allen, et al.
Published: (2019-11-01)

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
by: Hui Fang, et al.
Published: (2022-02-01)

Different preventive effects of four cardioprotective agents on mice with adriamycin-induced cardiotoxicity
by: CHEN Yifan, SHEN Yihui, CHENG Leilei, LIN Jinyi, ZHANG Hui, WANG Xuejun, XU Yuchen, ZHANG Jian, GE Junbo
Published: (2022-10-01)

FT- SERS Study of Adriamycin - DNA Intraction
by: Amanollah Aminzadeh
Published: (2003-04-01)